Emergent Biosolutions
EBS
EBS
169 hedge funds and large institutions have $352M invested in Emergent Biosolutions in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 48 increasing their positions, 54 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
5.09% more ownership
Funds ownership: 73.07% → 78.16% (+5.1%)
5% more funds holding
Funds holding: 161 → 169 (+8)
11% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 54
Holders
169
Holding in Top 10
2
Calls
$8.26M
Puts
$2.34M
Top Buyers
| 1 | +$6.22M | |
| 2 | +$5.17M | |
| 3 | +$4.49M | |
| 4 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$2.88M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.57M |
Top Sellers
| 1 | -$5.98M | |
| 2 | -$2.23M | |
| 3 | -$2.12M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.94M |
| 5 |
Morgan Stanley
New York
|
-$1.8M |
